Source: Davit Kirakosyan
HealthEquity Shares Plunge on Weak Q4 Earnings and Muted 2026 Outlook
Shares of HealthEquity (NASDAQ:HQY), a leading provider of health savings accounts (HSAs), tumbled over 18% in intra-day trading today. The sudden decline came in the wake of a disappointing fourth-quarter earnings report, and a muted 2026 guidance, which fell slightly below analyst expectations. This news overshadowed the company’s robust revenue growth, and led to a dampening of investor sentiment towards the stock.
The Weaker-Than-Expected Q4 Earnings
For the fourth quarter, HealthEquity reported adjusted earnings per share (EPS) of $0.69, falling short of the $0.72 consensus estimate by analysts. This underperformance marked a negative surprise for investors who were expecting the company to meet or exceed earnings forecasts. The missed earnings put pressure on the stock, contributing to the significant intra-day sell-off witnessed in the market.
Despite the earnings miss, the company did manage to deliver solid revenue growth. Revenue for the quarter climbed 19% year-over-year to reach $311.8 million, comfortably surpassing the forecast of $305.82 million. This revenue beat, however, was not enough to offset the disappointing earnings, leading to an overall negative market reaction.
Fiscal 2026 Outlook Falls Short of Expectations
Adding to the bearish sentiment, HealthEquity’s fiscal 2026 outlook came in slightly below market expectations. The company projected an EPS in the range of $3.57 and $3.74, which aligns closely with the $3.66 analysts’ consensus. However, the revenue guidance of $1.28 billion to $1.305 billion came in just shy of the expected $1.309 billion.
The muted guidance suggests that while the company expects continued growth, it may not be as robust as investors had hoped for. This could potentially indicate a deceleration in the company’s growth trajectory, adding another layer of concern for investors.
Strong Health Savings Account (HSA) Growth
Despite the disappointing earnings and subdued guidance, one bright spot in HealthEquity’s financial report was the continued strong growth in its HSA business. The company ended the quarter with 9.9 million health savings accounts, reflecting a healthy 14% increase year-over-year. Moreover, the total HSA assets managed by the company surged 27% to reach $32.1 billion.
This robust growth in HSA accounts and assets is a positive sign, indicating that the company continues to successfully attract and retain customers in its core business segment. This could provide a solid foundation for future revenue and earnings growth, assuming the company can maintain this momentum.
Fiscal 2025 Performance: Revenue and Earnings Growth
For fiscal 2025, HealthEquity posted $1.2 billion in revenue, representing a 20% annual increase. This strong revenue growth was accompanied by a significant increase in adjusted EBITDA, which rose 28% to $471.8 million. This corresponds to 39% of total revenue, up from 37% in the prior year.
The increase in both revenue and adjusted EBITDA indicates that the company was able to effectively manage its costs and improve its operational efficiency during the year. This is a promising sign for the company’s financial health and profitability, especially in light of the recent earnings miss and subdued guidance.
In conclusion, while HealthEquity’s Q4 earnings miss and muted 2026 outlook have certainly shaken investor confidence, the company’s strong HSA growth and fiscal 2025 performance provide some grounds for optimism. It remains to be seen how the company will maneuver through the challenges ahead and whether it can deliver on its growth potential.